Rank 3 • Biotech & Discovery
Isomorphic Labs
Reimagines drug discovery from first principles using deep learning models to predict molecular structures.
Visit website- Signal Score
- 94.8
- Total raised
- $100M
- Stage
- Growth
- Founded
- 2021
- Headquarters
- London, UK
- Region
- Europe
Their signal
An Alphabet spinoff powered by DeepMind's AlphaFold, Isomorphic Labs is pioneering AI-driven de novo drug design, securing high-profile commercial partnerships with major pharmaceutical leaders like Eli Lilly.
Signal Score 94.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.